Faster to single cells using miniature grinder
2021.03.10 – BIOPRO
BIOPRO features the FFX TissueGrinder in their dossiers on Cancer therapy/diagnostics and Disease prevention through better diagnostics.
Keine Moulinette - FFX Company Portrait
2021.02.09 – LABORJOURNAL
In its January/February edition 2021, LABORJOURNAL features a portrait of how FFX is starting up to commercialize the TissueGrinder technology.
Die Gewebe-Spalter - Press release
2020.09.30 – Fraunhofer IPA
FFX commercializes the TissueGrinder technology developed at Fraunhofer IPA – unlocking the door to innovations in personalized medicine.